APPMEDIC
ActiveSummary
The computed 12-month bankruptcy probability of APPMEDIC is 3.5% (moderate). The 2024 annual accounts show equity of €77k and a net result of €73k. The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2024
Axes · tick = 2023
Profitability100▲+1
Solvency98▼-2
Growth78
Track record94
Bankruptcy probability, 12 months
3.5%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €6k at 30 days acceptable
Liquidity ample (current ratio 3.75 against 3.94 in 2023; short-term debt: 26.7% and cash: 100% of total assets), and 26.7% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-06-2025, 31 days ahead of the deadline.
NBB · 2 filingsDeviation from the deadline
2025
not confirmed
2024
31 d early
2023
35 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, micro schema
Equity
€77k▲ 1,619%
2023 · €4k
2023: €4k
2024: €77k▲ +1619% vs 2023
2023 → 2024
Total assets
€105k▲ 1,649%
2023 · €6k
2023: €6k
2024: €105k▲ +1649% vs 2023
2023 → 2024
Net result
€73k▲ 4,781%
2023 · €1k
2023: €1k
2024: €73k▲ +4781% vs 2023
2023 → 2024
Working capital
€77k▲ 1,619%
2023 · €4k
2023: €4k
2024: €77k▲ +1619% vs 2023
2023 → 2024
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20232024Trend
Equity€4k-€77k▲ 1,619%
2023: €4k
2024: €77k▲ +1619% vs 2023
Operating result€2k-€100k▲ 5,273%
2023: €2k
2024: €100k▲ +5273% vs 2023
Net result€1k-€73k▲ 4,781%
2023: €1k
2024: €73k▲ +4781% vs 2023
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result rises in 2024; 2024 is 5,273% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Equity and liabilities €105k
Equity
€77k ▲ 1,619%
Debt
€28k ▲ 1,737%
Debt's share of the balance-sheet total rises from 25.4% to 26.7%. Equity and debt are higher.
Key figures and ratios
Current ratio
3.75▼
2023 · 3.94
Debt to equity
0.36▲
2023 · 0.34
ROE
94.2%▲
2023 · 33.2%
ROA
69.1%▲
2023 · 24.7%
Debt ≤ 1 year
€28k▲
2023 · €2k
Income taxes
€27k▲
2023 · €360
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 31 lines
Balance sheet
Code20232024
Assets
Total assets20/58€6k€105k▲
Current assets29/58€6k€105k▲
Cash at bank and in hand54/58€5k€105k▲
Deferred charges and accrued income490/1€768-
Equity and liabilities
Total equity and liabilities10/49€6k€105k▲
Equity10/15€4k€77k▲
Contributions10/11€3k€3k=
Reserves13-€73k
Distributable reserves133-€73k
Profit (loss) carried forward14€1k€2k▲
Amounts payable17/49€2k€28k▲
Amounts payable within one year42/48€2k€28k▲
Trade debts44€768-
Suppliers440/4€768-
Taxes, remuneration and social security45€360€28k▲
Taxes450/3€360€28k▲
Other amounts payable47/48€400€470▲
Income statement
Code20232024
Gross operating margin9900€2k€100k▲
Operating profit (loss)9901€2k€100k▲
Financial income75/76B-€212
Recurring financial income75-€212
Financial charges65/66B€9€46▲
Recurring financial charges65€9€46▲
Profit (loss) for the period before taxes9903€2k€100k▲
Income taxes67/77€360€27k▲
Profit (loss) for the period9904€1k€73k▲
Profit (loss) for the period to be appropriated9905€1k€73k▲
Appropriation of the result
Profit (loss) to be appropriated9906€1k€74k▲
Profit (loss) brought forward from the previous period14P-€1k
Transfer to equity691/2-€73k
To other reserves6921-€73k
The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Accounts by statement
| Line | 2023 | 2024 | Change |
|---|---|---|---|
| Gross operating margin9900 | €2k | €100k | ▲ 5,273% |
| Operating profit (loss)9901 | €2k | €100k | ▲ 5,273% |
| Financial income75/76B | - | €212 | - |
| Recurring financial income75 | - | €212 | - |
| Financial charges65/66B | €9 | €46 | ▲ 422% |
| Recurring financial charges65 | €9 | €46 | ▲ 422% |
| Profit (loss) for the period before taxes9903 | €2k | €100k | ▲ 5,307% |
| Income taxes67/77 | €360 | €27k | ▲ 7,482% |
| Profit (loss) for the period9904 | €1k | €73k | ▲ 4,781% |
| Profit (loss) for the period to be appropriated9905 | €1k | €73k | ▲ 4,781% |
| Line | 2023 | 2024 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €6k | €105k | ▲ 1,649% |
| Current assets29/58 | €6k | €105k | ▲ 1,649% |
| Cash at bank and in hand54/58 | €5k | €105k | ▲ 1,904% |
| Deferred charges and accrued income490/1 | €768 | - | - |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €6k | €105k | ▲ 1,649% |
| Equity10/15 | €4k | €77k | ▲ 1,619% |
| Contributions10/11 | €3k | €3k | = |
| Reserves13 | - | €73k | - |
| Distributable reserves133 | - | €73k | - |
| Profit (loss) carried forward14 | €1k | €2k | ▲ 3.0% |
| Amounts payable17/49 | €2k | €28k | ▲ 1,737% |
| Amounts payable within one year42/48 | €2k | €28k | ▲ 1,737% |
| Trade debts44 | €768 | - | - |
| Suppliers440/4 | €768 | - | - |
| Taxes, remuneration and social security45 | €360 | €28k | ▲ 7,564% |
| Taxes450/3 | €360 | €28k | ▲ 7,564% |
| Other amounts payable47/48 | €400 | €470 | ▲ 17.5% |
| Line | 2023 | 2024 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | €1k | €73k | ▲ 4,781% |
| Operating cash flow (approximation) | €1k | €73k | ▲ 4,781% |
| Change in cash | - | €100k | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
30-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
26-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
NBB filing
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Ottignies-Louvain-la-Neuve · 1 establishment unit since 2023
Ground area
5.2 ha
Building footprint
92 m²
Volume, LiDAR
598 m³
2 parcels, Brussels, Wallonia · tallest building 8.0 m, ±2 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
APPMEDIC
since 20232.352.465.873
2 parcels
Wallonia
1
(50%)
Brussels
1
(50%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21018B0078/00R002 | Brussels | 5.0 ha | - | - |
| 25056A0428/00E000 | Wallonia | 1,286 m² | 1 · 92 m² | 8.0 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Identification & contact
Identification
Legal formPrivate limited company
Founded21-09-2023
Fiscal year end31-12
Scores and ratios are computed by Checked and are not a credit decision.